Chemed (CHE) Expected to Announce Quarterly Earnings on Wednesday

Chemed (NYSE:CHE) is expected to issue its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $7.02 per share and revenue of $659.0860 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:00 AM ET.

Chemed Stock Up 0.8%

Shares of CHE opened at $479.09 on Tuesday. Chemed has a 52-week low of $408.42 and a 52-week high of $623.60. The stock has a market cap of $6.78 billion, a PE ratio of 25.34, a price-to-earnings-growth ratio of 2.32 and a beta of 0.44. The firm’s fifty day moving average is $445.75 and its two-hundred day moving average is $443.99.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio is presently 12.69%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CHE. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, January 21st. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Finally, Royal Bank Of Canada lowered their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Three equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Chemed currently has a consensus rating of “Moderate Buy” and a consensus price target of $555.50.

Hedge Funds Weigh In On Chemed

Several large investors have recently made changes to their positions in CHE. EntryPoint Capital LLC acquired a new position in Chemed during the fourth quarter worth $383,000. Morningstar Investment Management LLC acquired a new stake in shares of Chemed in the third quarter valued at $387,000. Virtus Advisers LLC purchased a new stake in shares of Chemed in the 3rd quarter valued at $401,000. Entropy Technologies LP raised its holdings in shares of Chemed by 35.1% in the 4th quarter. Entropy Technologies LP now owns 1,216 shares of the company’s stock valued at $520,000 after buying an additional 316 shares during the period. Finally, Vident Advisory LLC lifted its stake in Chemed by 28.3% during the 2nd quarter. Vident Advisory LLC now owns 947 shares of the company’s stock worth $461,000 after acquiring an additional 209 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.